Mock, Elliot D. http://orcid.org/0000-0002-1500-2856
Mustafa, Mohammed
Gunduz-Cinar, Ozge
Cinar, Resat http://orcid.org/0000-0002-8597-7253
Petrie, Gavin N.
Kantae, Vasudev
Di, Xinyu
Ogasawara, Daisuke http://orcid.org/0000-0002-2178-4698
Varga, Zoltan V.
Paloczi, Janos
Miliano, Cristina
Donvito, Giulia
van Esbroeck, Annelot C. M. http://orcid.org/0000-0003-0631-2403
van der Gracht, Anouk M. F.
Kotsogianni, Ioli
Park, Joshua K.
Martella, Andrea
van der Wel, Tom http://orcid.org/0000-0002-6449-3233
Soethoudt, Marjolein
Jiang, Ming
Wendel, Tiemen J.
Janssen, Antonius P. A. http://orcid.org/0000-0003-4203-261X
Bakker, Alexander T.
Donovan, Colleen M.
Castillo, Laura I.
Florea, Bogdan I.
Wat, Jesse
van den Hurk, Helma
Wittwer, Matthias
Grether, Uwe
Holmes, Andrew
van Boeckel, Constant A. A.
Hankemeier, Thomas
Cravatt, Benjamin F. http://orcid.org/0000-0001-5330-3492
Buczynski, Matthew W.
Hill, Matthew N.
Pacher, Pal http://orcid.org/0000-0001-7036-8108
Lichtman, Aron H.
van der Stelt, Mario http://orcid.org/0000-0002-1029-5717
Funding for this research was provided by:
Innovative Medicines Initiative (n°115489)
Article History
Received: 12 February 2019
Accepted: 27 March 2020
First Online: 11 May 2020
Competing interests
: E.M., I.K. C.B. and M.v.d.S. are listed as inventors on patent application WO 2019/229250 A1 filed by Leiden University in which inhibitors of NAPE-PLD are disclosed.